PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2018

Arctigenin protects against liver injury from acute hepatitis by suppressing immune cells in mice.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29579707 ↗2018Reported benefit

Arctigenin protects against liver injury from acute hepatitis by suppressing immune cells in mice.

MouseChemical/toxinBALB/cMale

Model: Concanavalin A (ConA)-induced acute hepatitis

Arctigenin reduced liver congestion and necroinflammation, improved hepatic ALT and AST, decreased hepatic infiltration of CD4 T cells, NKT cells and macrophages, and suppressed ConA-induced T lymphocyte proliferation, partly via enhanced IL-10 production, in a mouse model of ConA-induced acute hep…

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.